Friday, July 10, 2026

pharma · Atopic Dermatitis · COVID-19

Qilu Pharmaceuticals

Qilu Pharmaceuticals trial registry — 2 ClinicalTrials.gov studies with program phase, status, and indication context.

CN HQ
1958 Founded
243 Employees
NMPA registrant Type
Company details
Status
Public
HQ
CN
Founded
1958
Employees
243
Programs
2
Drugs
4
Patents
0
Intelligence · Clinical Trials

Qilu Pharmaceuticals clinical trials

Registry index of 2 ClinicalTrials.gov studies linked to Qilu Pharmaceuticals programs — each row shows trial ID, program name, phase, status, and indication.

Qilu Pharmaceuticals trial registry — 2 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

2 updates

Latest clinical program signals indexed for Qilu Pharmaceuticals.

  1. QLS1128 A-Dose 1~5 and Ritonavir — Phase 1

    Clinical update
  2. QL2108 injection — Phase 1

    Clinical update

Trial registry

2 studies